Mitigate Unblinding Risks

Every clinical trial runs the risk of unintentional unblinding. With 30 years of experience designing reliable RTSM solutions and the processes behind it, Calyx IRT is the solution you can rely on to minimize these risks and ensure the integrity of your clinical trial.

The solution design and technical experts behind Calyx IRT have published a variety of resources to demonstrate where and how unblinding can occur and more importantly, how to minimize those risks.

Access them below!

TALK TO OUR IRT EXPERTS

Blogs

Untitled-14

Minimize Data-related Unblinding Risks: Your Questions Answered

Untitled-14

Minimize Unblinding Risks during Randomization: Your Questions Answered

16SEP2022-UnblindingBlog3_header2000x1000_V1

Clinical Trial Unblinding: What it is and what it isn’t

26AUG2022-unblindingblog2_header2000x1000_v1

How Unintentional Unblinding Occurs in Clinical Trials

In Clinical Trials, it’s all about the Blind

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.